Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Lantz

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Transplantation Proceedings|August 1, 1990
High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppressionC Hiesse, N Neyrat, M Busson, et al.
Transplantation Proceedings|October 1, 1987
Optimal results in cadaver-donor renal transplantation using prophylactic ALG, cyclosporine, and prednisoneC Hiesse, D Fries, B Charpentier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1987
rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2M H Ben Aribia, E Leroy, O Lantz, et al.
Annales D'Urologie|January 1, 1988
[The value of dual kidney and pancreas transplantation, with bladder drainage in type I diabetic patients with renal insufficiency]G Benoit, P Bouchard, B Charpentier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2001
Effect of highly active antiretroviral therapy on expression of interleukin-10 and interleukin-12 in HIV-infected patientsY Taoufik, I Peguillet, M G de Goër, et al.
Transplantation Proceedings|June 1, 1988
Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantationD Fries, C Hiesse, G Santelli, et al.
AIDS (London, England)|April 15, 1999
Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapyF Martinon, C Michelet, I Peguillet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 1, 1991
[Urological complications in renal transplantation]N Thiounn, G Benoit, C Osphal, et al.
Transplantation Proceedings|February 1, 1989
Triple-drug regimen (TDR) of AZA + CsA + P: new definition of factors influencing kidney graft survival at a single centerC Hiesse, P Prevost, M Busson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Prophylactic use of the IL-2 receptor-specific monoclonal antibody LO-Tact-1 with cyclosporin A and steroids in renal transplantationC Hiesse, F Kriaa, P Alard, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Transplantation Proceedings|August 1, 1990
High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppressionC Hiesse, N Neyrat, M Busson, et al.
Transplantation Proceedings|October 1, 1987
Optimal results in cadaver-donor renal transplantation using prophylactic ALG, cyclosporine, and prednisoneC Hiesse, D Fries, B Charpentier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1987
rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2M H Ben Aribia, E Leroy, O Lantz, et al.
Annales D'Urologie|January 1, 1988
[The value of dual kidney and pancreas transplantation, with bladder drainage in type I diabetic patients with renal insufficiency]G Benoit, P Bouchard, B Charpentier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2001
Effect of highly active antiretroviral therapy on expression of interleukin-10 and interleukin-12 in HIV-infected patientsY Taoufik, I Peguillet, M G de Goër, et al.
Transplantation Proceedings|June 1, 1988
Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantationD Fries, C Hiesse, G Santelli, et al.
AIDS (London, England)|April 15, 1999
Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapyF Martinon, C Michelet, I Peguillet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 1, 1991
[Urological complications in renal transplantation]N Thiounn, G Benoit, C Osphal, et al.
Transplantation Proceedings|February 1, 1989
Triple-drug regimen (TDR) of AZA + CsA + P: new definition of factors influencing kidney graft survival at a single centerC Hiesse, P Prevost, M Busson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Prophylactic use of the IL-2 receptor-specific monoclonal antibody LO-Tact-1 with cyclosporin A and steroids in renal transplantationC Hiesse, F Kriaa, P Alard, et al.
Pageof 9